Prokidney annual stock-based compensation
2020
2021
2022
2023
2024
2025
Prokidney Stock-Based Compensation Growth & History (PROK)
Prokidney's stock-based compensation was $25.3M for fiscal 2025.
View full Prokidney company overviewProkidney annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $25.3M | −$4.0M | −13.74% |
| 2024 | 2024-12-31 | $29.4M | −$1.5M | −4.78% |
| 2023 | 2023-12-31 | $30.8M | −$43.6M | −58.58% |
| 2022 | 2022-12-31 | $74.5M | $73.8M | +10553.65% |
| 2021 | 2021-12-31 | $699,000 | −$31,000 | −4.25% |
| 2020 | 2020-12-31 | $730,000 | — | — |
Prokidney quarterly stock-based compensation
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $5.6M | −$947,000 | −14.48% |
| Q1 2026 | 2026-03-31 | $4.9M | −$1.5M | −22.93% |
| Q4 2025 | 2025-12-31 | $5.7M | −$1.2M | −17.92% |
| Q3 2025 | 2025-09-30 | $6.7M | −$259,000 | −3.73% |
| Q2 2025 | 2025-06-30 | $6.5M | −$1.3M | −16.25% |
| Q1 2025 | 2025-03-31 | $6.4M | −$1.3M | −16.45% |
| Q4 2024 | 2024-12-31 | $6.9M | — | — |
| Q3 2024 | 2024-09-30 | $6.9M | −$6.1M | −46.63% |
| Q2 2024 | 2024-06-30 | $7.8M | −$3.4M | −30.28% |
| Q1 2024 | 2024-03-31 | $7.7M | −$5.3M | −41.02% |
| Q3 2023 | 2023-09-30 | $13.0M | $8.2M | +168.25% |
| Q2 2023 | 2023-06-30 | $11.2M | $3.2M | +40.01% |
| Q1 2023 | 2023-03-31 | $13.0M | −$39.7M | −75.29% |
| Q4 2022 | 2022-12-31 | $8.9M | — | — |
| Q3 2022 | 2022-09-30 | $4.8M | $4.7M | +2668.00% |
| Q2 2022 | 2022-06-30 | $8.0M | — | — |
| Q1 2022 | 2022-03-31 | $52.7M | — | — |
| Q3 2021 | 2021-09-30 | $175,000 | — | — |
Prokidney stock-based compensation trends
Over the last five fiscal years, Prokidney's stock-based compensation increased from $730,000 to $25.3M, a change of $24.6M. The latest reported quarter, Q2 2026, shows $5.6M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Prokidney source filings ↗